Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.leukres.2007.11.025
Title: In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor
Authors: Zhou, J. 
Khng, J.
Jasinghe, V.J. 
Bi, C.
Poon, L.F. 
Xie, Z. 
Chen, C.-S. 
Neo, C.H.S.
Pan, M.
Yu, H. 
Yeoh, A.E.-J. 
Lu, Y. 
Glaser, K.B.
Albert, D.H.
Davidsen, S.K.
Keywords: Acute myeloid leukemia
In vivo
Tyrosine kinase inhibitor
Whole-body imaging technology
Wild-type FLT3 receptor
Issue Date: 2008
Source: Zhou, J., Khng, J., Jasinghe, V.J., Bi, C., Poon, L.F., Xie, Z., Chen, C.-S., Neo, C.H.S., Pan, M., Yu, H., Yeoh, A.E.-J., Lu, Y., Glaser, K.B., Albert, D.H., Davidsen, S.K. (2008). In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor. Leukemia Research 32 (7) : 1091-1100. ScholarBank@NUS Repository. https://doi.org/10.1016/j.leukres.2007.11.025
Abstract: Neoangiogenesis plays an important role in leukemogenesis. We investigated the in vivo anti-leukemic effect of ABT-869 against AML with wild-type FLT3 using RFP transfected HL60 cells with in vivo imaging technology on both the subcutaneous and systemic leukemia xenograft models. ABT-869 showed a five-fold inhibition of tumor growth in comparison with vehicle control. IHC analysis revealed that ABT-869 decreased p-VEGFR1, Ki-67 labeling index, VEGF and remarkably increased apoptotic cells in the xenograft models. ABT-869 also reduced the leukemia burden and prolonged survival. Our study supports the rationale for clinically testing an anti-angiogenesis agent in AML with wild-type FLT3. © 2007 Elsevier Ltd. All rights reserved.
Source Title: Leukemia Research
URI: http://scholarbank.nus.edu.sg/handle/10635/26977
ISSN: 01452126
DOI: 10.1016/j.leukres.2007.11.025
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

20
checked on Dec 5, 2017

WEB OF SCIENCETM
Citations

18
checked on Nov 16, 2017

Page view(s)

151
checked on Dec 10, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.